You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 52 No. 2, AUGUST 1933 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

CHOLESTEROL AND LECITHIN. PHOSPHORUS IN THE PLASMA OF ANEMIA OTHER THAN PERNICIOUS ANEMIA

INFLUENCE OF THERAPEUTIC MEASURES ON THESE CONSTITUENTS

GULLI LINDH MULLER, M.D.; CLARK W. HEATH, M.D.

Arch Intern Med. 1933;52(2):288-305.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

A disturbance of cholesterol and lecithin metabolism frequently accompanies anemia. The literature1 reveals, however, a considerable variation in the results obtained by many observers, even when allowance is made for differences in technic. This variation may be partly due to deficient observations on the same patient and failure to correlate the various factors involved. In pernicious anemia there is a definite relationship between the stage of the disease and the lipoids of the blood.2 Cholesterol and, in many instances, the plasma lecithin phosphorus are decreased during a relapse, but as remission is inaugurated there occurs a sudden rise in the lipoids of the blood, concomitant with the reticulocyte response. This reaction develops before there is significant alteration in the concentration of the red blood cells or hemoglobin, and is apparently proportional to the rate of remission.

In so-called secondary anemia, which is usually of the hypochromic type, the . . . [Full Text PDF of this Article]


Author Affiliations

BOSTON

From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital, and the Department of Medicine, Harvard Medical School.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1933 American Medical Association. All Rights Reserved.